Accendra EVP surrenders 9,347 shares for taxes

Accendra Health executive Heath H. Galloway transferred 9,347 shares of common stock to the company at $2.03 per share to cover tax withholding on vested restricted stock.

Rhea-AI Filing Summary

Accendra Health executive Heath H. Galloway transferred 9,347 shares of common stock to the company at $2.03 per share to cover tax withholding on vested restricted stock. This non‑market, tax-withholding disposition leaves him holding 169,094 shares directly, reflecting a routine compensation-related adjustment rather than an open-market trade.

Insider Trade Summary

Exercise Price or Tax Liability: 9,347 shares

Exercise Price or Tax Liability 1 txn

Insider Galloway Heath H

Role EVP,General Counsel & CorpSecy

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	9,347	$2.03	$19K

Holdings After Transaction: Common Stock — 169,094 shares (Direct)

Footnotes (1)

1. F1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Accendra Health (ACH) report for Heath H. Galloway?

Accendra Health reported that EVP and General Counsel Heath H. Galloway surrendered 9,347 common shares at $2.03 each to the company. The shares were used to satisfy tax withholding obligations tied to vesting restricted stock, rather than an open-market sale of shares.

Was Heath H. Galloway’s Accendra Health Form 4 transaction an open-market sale of ACH stock?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Galloway surrendered 9,347 shares back to Accendra Health to cover taxes on vesting restricted stock, a routine administrative step associated with equity compensation, rather than a discretionary sale into the market.

How many Accendra Health (ACH) shares does Heath H. Galloway hold after this Form 4 transaction?

After the transaction, Heath H. Galloway directly holds 169,094 shares of Accendra Health common stock. This figure, reported in the Form 4, indicates his continuing equity stake following the tax-related share surrender connected to the vesting of a prior restricted stock grant.

What does transaction code "F" mean in the Accendra Health (ACH) Form 4 filing?

Transaction code "F" indicates payment of an exercise price or tax liability by delivering securities. In this filing, 9,347 Accendra Health shares were surrendered to satisfy tax withholding obligations arising from restricted stock vesting, rather than being sold into the public market.

Why were 9,347 Accendra Health (ACH) shares surrendered by Heath H. Galloway?

The 9,347 shares were surrendered to Accendra Health to cover tax withholding obligations triggered when Galloway’s restricted stock vested. This method uses a portion of vested shares to pay taxes, leaving the remaining vested shares in the executive’s direct ownership position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 05:40 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galloway Heath H

(Last) (First) (Middle)

ACCENDRA HEALTH INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP,General Counsel & CorpSecy

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		F		9,347(1)	D	$2.03	169,094	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Heath H. Galloway by Rosemarie France, POA	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)